CVRx, Inc.·4

Aug 4, 8:25 PM ET

Galle Liz 4

4 · CVRx, Inc. · Filed Aug 4, 2022

Insider Transaction Report

Form 4
Period: 2022-08-02
Galle Liz
VP of Global Clinical Research
Transactions
  • Award

    Stock Option (right to buy)

    2022-08-02+8,0008,000 total
    Exercise: $9.01Exp: 2032-08-01Common Stock (8,000 underlying)
Footnotes (1)
  • [F1]Vests as to 25% of the shares on August 2, 2023 and as to 1/48th of the shares each month thereafter.

Documents

1 file
  • 4
    form4-08042022_050857.xmlPrimary